Connect with us

Spread & Containment

Forced Vaccination Law In Denmark Abandoned After Public Protests

Forced Vaccination Law In Denmark Abandoned After Public Protests



Forced Vaccination Law In Denmark Abandoned After Public Protests Tyler Durden Wed, 11/18/2020 - 05:00

Authored by Paul Joseph Watson via Summit News,

A law in Denmark that would have given authorities the power to forcibly inject people with a coronavirus vaccine has been abandoned after nine days of public protests.

The ‘epidemic law’ would have handed the Danish government the power to enact mandatory quarantine measures against anyone infected with a dangerous disease, but it was the part about vaccinations that caused the biggest uproar.

“The Danish Health Authority would be able to define groups of people who must be vaccinated in order to contain and eliminate a dangerous disease,” reports the Local.

“People who refuse the above can – in some situations – be coerced through physical detainment, with police allowed to assist.”

However, after nine straight days of protests against the new law, it has now been scrapped.

With a coronavirus vaccine within sight, governments across the world are mulling over what punitive measures to bring against those who refuse to take it.

Last week we highlighted how both Ticketmaster and airline companies are considering barring people from entering venues and flying if they cannot prove they have taken the vaccine.

So while public protests may be able to prevent authorities carrying out forced vaccinations, people who refuse to take the shot may find it virtually impossible to enjoy any kind of social life, use public transport, or even find employment.

*  *  *

New limited edition merch now available! Click here.

In the age of mass Silicon Valley censorship It is crucial that we stay in touch. I need you to sign up for my free newsletter here. Also, I urgently need your financial support here.

Read More

Continue Reading


Ivermectin: Could Population-Wide Distribution Have Prevented China’s Recent Mass COVID Outbreak?

Ivermectin: Could Population-Wide Distribution Have Prevented China’s Recent Mass COVID Outbreak?

Authored by Dr. Sean Lin and Mingjia Jacky…



Ivermectin: Could Population-Wide Distribution Have Prevented China's Recent Mass COVID Outbreak?

Authored by Dr. Sean Lin and Mingjia Jacky Guan via The Epoch Times (emphasis ours),

China’s state-run medicare program recently failed to reach an agreement with Pfizer to import more Paxlovid, claiming the COVID-19 treatment drug is too expensive. This is despite the drug being offered to the state at a reduced rate in comparison with that offered to other developed countries. Lack of Paxlovid will leave only Azvudine, an anti-HIV drug the Chinese communist regime rushed through development and re-branded as an anti-COVID drug, as a treatment option.

An ivermectin bottle next to a positive blood sample of COVID-19. (Novikov Aleksey/Shutterstock)

Given the recent explosive spread of COVID and the resulting skyrocketing rates of hospitalization, finding viable treatment options is paramount.

Ivermectin in India and Peru

When the Delta variant broke out in 2021 across India, many states offered ivermectin population-wide. The efficacy of ivermectin in treating early and mild COVID-19 infections was confirmed in large states such as Uttar Pradesh—home to 241 million residents—where the use of the prophylactic dramatically reduced both the infection rate and the death toll.

Data from a study comparing the efficacy of ivermectin in frontline health care workers. (The Epoch Times)

Even among frontline health care workers, ivermectin proved to be an effective prophylactic against COVID-19. One study with 3,532 frontline health care workers from the All India Institute of Medical Sciences Bhubaneswar found that two doses of oral ivermectin (300 μg/kg given 72 hours apart) as chemoprophylaxis among health care workers reduced the risk of COVID-19 infection by 83 percent in the following month.

In Peru, mass ivermectin treatments were conducted through a broad-scale effort called Mega-Operación Tayta, or MOT for short. Operation MOT was led by the Peruvian army and involved 10 states, where the excess death rate saw a sharp decline with an average of 74 percent over 30 days. In 14 states where ivermectin was administered locally, the mean reduction in excess deaths over 30 days compared with deaths was 53 percent.

Lima, the capital of Peru, where the distribution of ivermectin was restricted, saw only a 25 percent reduction in excess deaths. The findings of researchers, detailed in the diagram below, show infection numbers, deaths, and fatalities across Peruvian states which implemented ivermectin (blue) and those which did not (red). The conclusion is that a reduction in deaths correlated with the distribution of ivermectin with a statistically significant p-value of less than 0.002.

COVID-19 data from Peru’s 2021 Delta outbreak comparing states that dispensed ivermectin (green) and those that did not (blue). (The Epoch Times)

Ivermectin–The Wonder Drug

Ivermectin was discovered in Japan during the late 70s as a derivative of Avermectin, produced from a single organism isolated at the Kitasato Institute in Tokyo. Since then, ivermectin has played an immeasurable role in improving the lives of billions with its humble beginnings as an anti-parasitic drug.

Ivermectin, approved by the U.S. Food and Drug Administration and deployed worldwide since 1987, has made major inroads against two devastating tropical diseases—onchocerciasis and lymphatic filariasis. In addition, some topical forms of ivermectin are approved to treat external parasites like head lice and skin conditions such as rosacea.

Ivermectin is potentially effective against a host of viruses. (The Epoch Times)

In addition to its anti-parasitic effects, a 2022 study published in the European Journal of Medicinal Chemistry Reports found that ivermectin has a strong potency at low concentrations against many DNA and RNA viruses, including HIV-1, yellow fever, malaria, West Nile virus, Zika, dengue fever, etc.

According to the study, ivermectin has an amazing inhibitory effect across multiple species and can interrupt motility and reproduction in both arthropods (such as insects) and nematodes (such as roundworms). This explains why ivermectin is prescribed for parasite infections, and also sheds light on its potential as a prophylactic against vector-borne diseases. In insects and other arthropods specifically, it can interrupt the transmission of disease.

Ivermectin’s Potential Mechanisms Against COVID

SARS-CoV-2 is a virus that takes over host cells to multiply in the body. To enter the host cells, the virus binds to the ACE-2 receptor on the surface of cells which grants them entry. Ivermectin prevents the bonding process by interfering with the virus’s spike proteins—this is the same mechanism the vaccines use.

If the virus slips past the cell membrane, its top priority is to infiltrate the brain of the cell—the DNA-containing nucleus—to start mass-producing itself. SARS-CoV-2 latches itself onto a special class of transport proteins called IMPs that have enough security clearance to enter the nucleus. In the case of a viral infection, ivermectin binds to these transport proteins and halts the interaction.

Ivermectin inhibiting intracellular transport and viral production. (The Epoch Times)

Ivermectin also inhibits the nuclear transport mechanism mediated by the KPNA-1 protein, which has a similar effect when compared with IMPs. Both proteins can enter the nucleus and ivermectin can effectively stop the virus from getting to the nucleus. In the event that the virus does manage to invade the nucleus—ivermectin also has a backup plan.

For example, when the virus has taken over and initialized self-replication, it does so through a protein called RdRp, which is at the centerpiece of viral replication—and is directly inhibited by ivermectin with very high efficacy.

Ivermectin Could Reduce Severe Lung Damage in COVID Patients

Once COVID-19 reaches later stages, it may require intensive care for recovery. For example, white lung syndrome (a hallmark symptom of acute respiratory distress syndrome) now occurring in severe COVID infections in China, is a sign that the virus has deeply infected the lungs and may have caused cytokine storms (a severe immune reaction in the body) in patients.

Other complications that arise from COVID-19 involving the lungs are conditions such as pulmonary fibrosis and hypoxia. Hypoxia occurs when the virus infects lung tissue to the extent that the alveoli, tiny sacs of air at the end of lung branches responsible for oxygen exchange, become scarred causing a severe loss of oxygen in the body.

Cytokines and chemokines are responsible for inflammation, a natural immune system response to foreign invaders. However, a large number of cytokines released into the body all at once can cause a “cytokine storm,” wherein the body is flooded with armies of white blood cells that harm the body.

A cytokine storm can be triggered through the TLR-4 pathway by the virus. The same pathway also triggers the release of nitric oxide, causing fluid leaks, dilating blood vessels, or even sepsis and fluid buildup in the lungs.

Read more here...

Tyler Durden Tue, 01/31/2023 - 23:40

Read More

Continue Reading


Genomic methods aid study of Seattle 2017-2022 Shigella outbreak

A genomic study of a sustained, multidrug-resistant Shigellosis outbreak in Seattle enabled scientists to retrace its origin and spread. Additional analysis…



A genomic study of a sustained, multidrug-resistant Shigellosis outbreak in Seattle enabled scientists to retrace its origin and spread. Additional analysis of the gut pathogen and its transmission patterns helped direct approaches to testing, treatment, and public health responses.  

Credit: Jason Matsumoto, Harborview Microbiology Lab

A genomic study of a sustained, multidrug-resistant Shigellosis outbreak in Seattle enabled scientists to retrace its origin and spread. Additional analysis of the gut pathogen and its transmission patterns helped direct approaches to testing, treatment, and public health responses.  

The genomic reconstruction of the 2017-2022 outbreak and a review of the patient care and public health interventions used are reported Jan 30 in The Lancet Infectious Diseases.

“The aim of the study,” the Seattle researchers noted, “was to better understand the community transmission of Shigella and spread of antimicrobial resistance in our population, and to treat these multi-drug resistant infections more effectively.”

Shigella outbreaks are more frequent in countries without sufficient public health and sanitation resources.  But the researchers called Shigella an opportunistic pathogen that can also emerge in regions of high-income countries when conditions allow.

They explained that sustained Shigella outbreaks in urban areas pose a substantial public health challenge for populations trying to cope with harsh living conditions and lack of hygiene facilities.

The lead authors on the paper are Dr. Giannoula S. Tansarli of the Department of Laboratory Medicine and Pathology, and Dr. Dustin R. Long, of the Division of Critical Care Medicine, Department of Anesthesiology, both at the University of Washington School of Medicine.

The senior and corresponding author is Dr. Ferric C. Fang, professor of laboratory medicine and pathology and of microbiology at the UW medical school.  He oversees the clinical microbiology lab at Harborview Medical Center and conducts basic science research on how bacteria cause disease. He was assisted by his UW Medicine colleague Dr. Stephen J. Salipante, a molecular genetics pathologist and an expert on next-generation DNA sequencing technologies.

Shigellosis is caused by Shigella bacteria, which can produce inflammation in the lining of the intestine. Its symptoms include fever, stomach cramps and diarrhea, and, in the worse cases, dysentery and dehydration. Some people with Shigellosis become severely ill and require hospitalization.  Shigellosis is highly contagious. The transmission of just a few bacteria is sufficient to cause disease.

From 2017 to 2022, all 178 cases of Shigella identified by the clinical labs at Harborview Medical Center and UW Medical Center were characterized by species identification, susceptibility testing, and whole genome sequencing. For the study, the researchers retrospectively examined the demographics and the clinical outcomes of the infected patients.  

Of the 178 cases, 78, or 45.6%, were in men who have sex with men, and 88, or 51.5% were in persons experiencing homelessness. About half of the Shigella isolates were resistant to multiple antibiotics.

The researchers also had data on 143 patients who received antimicrobial therapy. Despite the high presence of drug resistant Shigella, nearly 70 percent of patients were found to have received suitable antimicrobial therapy for their Shigella infection. The researchers added that rapid diagnostics and culturing of the bacteria for patients seeking care for severe diarrhea, along with assessment of risk factors and detailed local understanding of the populations affected, led to high rates of appropriate treatment. The approach to care improved over time, as clinicians gained more experience with the disease.

The genomic analysis portion of the study revealed sequential outbreaks of several distinct lineages of two species of ShigellaS. flexneri and S. sonnei. The various at-risk populations were found to carry Shigella of different lineages with different drug-resistance traits.  This information helped clinicians develop effective treatment guidelines.

How did this Shigella outbreak appear in Seattle? The researchers’ genomic findings suggest that it came originally from international travelers from areas where Shigella was common. It then spread locally and quickly among at-risk groups.

The researchers explained that multi-drug resistant Shigella has become a growing global health concern with many outbreaks worldwide. Most of these have affected men who have sex with men. A variety of gut pathogens can be transmitted between men in this way.

However, in the past few years Shigellosis outbreaks also have occurred among people experiencing homelessness in West Coast cities of the United States and Canada.

Whole-genome sequencing enabled the researchers to determine that new S. sonnei and S. flexneri  strains first appeared in Seattle among men who have sex with men. This was quickly followed by transmission within the local population of people experiencing homelessness. This was evidenced by the significant increase in Shigellosis after 2020 in the Seattle-King County area among this population.

The outbreaks were worse in winter, a seasonal characteristic of Shigella which might be due to greater overcrowding in shelters and other locations during cold weather. Dr. Fang noted that Shigellosis cases caused by a different S. sonnei strain are now being encountered in Seattle this winter.

The Seattle outbreaks followed patterns characteristic of those reported earlier in other countries.

Several public health measures were instituted to limit the spread of Shigella. The first was to check for possible sources for contracting Shigella. Signs were placed to discourage people from drinking water from decorative fountains in downtown Seattle. Local homeless service providers received prevention resources and guidance. Outreach teams visited encampments and overnight shelters to offer health education and improve the availability of clean water, toilets, handwashing stations, and other sanitation measures.

Many public facilities, such as restrooms, sinks, and drinking fountains, had been closed as part of the COVID-19 pandemic response. Public health officials requested early re-opening of these facilities near encampments and districts where people lived on the streets. They also increased environmental cleaning of alleyways in downtown Seattle that had been used in lieu of restrooms.

The authors noted that the study of the Shigella outbreak in Seattle represented the collaborative efforts of local health-care facilities, clinical and academic laboratories, antimicrobial stewardship, infection control, and public health teams.

The study received no outside funding, and the researchers declared no competing interests.



Read More

Continue Reading


Heart, Vein Disease Deaths High In 25-To-44-Year-Olds

Heart, Vein Disease Deaths High In 25-To-44-Year-Olds

Authored by Petr Svab via The Epoch Times (emphasis ours),

Diseases of the heart and…



Heart, Vein Disease Deaths High In 25-To-44-Year-Olds

Authored by Petr Svab via The Epoch Times (emphasis ours),

Diseases of the heart and veins claimed more lives over the past several years among American aged 25 to 44 than before the COVID-19 pandemic. Even with the pandemic waning, such deaths remain elevated.

An ambulance outside the Bellville Medical Center after dropping off a patient, in Bellville, Texas, on Sept. 1, 2021. (Francois Picard/AFP via Getty Images)

In 2020, the first year of the pandemic, deaths caused by circulatory diseases increased by about 15 percent in the 25 to 44 age group compared to the year before, according to death certificate data collected by the Centers for Disease Control and Prevention (CDC).

In 2021, such deaths increased by more than 20 percent compared to 2019.

That means nearly 6,500 more deaths.

(ZH: Related)

It appears that the increase may have been caused by multiple factors.

COVID-19 sometimes causes complications in the circulatory system. It’s likely that some deaths, especially early on in the pandemic, were caused by COVID-19 but were misclassified on the death certificate.

Also, many people were likely diagnosed too late or not at all because they were afraid to go to a doctor during the pandemic.

However, diseases of the circulatory system continued to claim lives at a higher rate in this age group even in 2022, when the pandemic receded. In the first half of the year, such deaths were still more than 13 percent above the death toll for the first half of 2019, according to the CDC’s preliminary data.

In the 45 to 54 age group, such deaths increased in 2020–21 but seem to have since receded back to pre-pandemic levels.

In the 15 to 24 age group, such deaths have barely budged over the past five years.

A growing number of experts and studies have associated the COVID-19 vaccines with serious, even fatal conditions, including heart inflammation, or myocarditis. They suggest that the spike protein produced through the vaccination can cause blood clotting and inflammation.

“All cardiovascular conditions have gotten worse because of the vaccine and anything and everything that can go wrong with the heart has gone wrong with the heart as a result of these mRNA vaccines. There’s no doubt about it,” said Dr. Aseem Malhotra, a British cardiologist who has researched extensively the associations between the COVID-19 vaccines and heart issues.

Malhotra has argued that such issues should be presumed to be associated with the vaccines until proven otherwise. He initially supported the vaccines but changed his mind after his father’s cardiac arrest six months after vaccination.

Dr. Peter McCullough, a highly published American cardiologist, independently reached a similar conclusion.

When people are in a study or it’s in a post-marketing period in a brand-new drug, when someone dies within a few days, or certainly within 30 days of any new drug or injection, it is that drug until proven otherwise,” he told Epoch TV’s Jan Jekielek last month.

“If this was in a regulatory dossier, it could even be something that’s seemingly disconnected. Believe it or not, in clinical trials, if someone’s taking a drug and they have a car accident, it’s attributed to the drug, because the drug may have made them dizzy or foggy or what have you.”

The rollout of the vaccines also correlates with significant increases in other conditions, including eye problems, immune system issues, and, in some data, cancer, according to Josh Stirling, an insurance research analyst.

Overall, the vaccination correlates with increased mortality, according to Stirling.

“The more doses on average you have in a region within the United States, the bigger increase in mortality that region has had in 2022 when compared to 2021,” he recently told Jekielek in an interview for “American Thought Leaders.”

Stirling has argued that if the vaccine’s adverse effects are properly identified, they could be mitigated.

“If we were actually just screening for these people, the vast majority of these health issues, before they become catastrophic, could very easily be managed—not necessarily solved, but certainly managed with amazing medical advances and simple things like blood thinners, or changes in lifestyle,” he said.

Mortality in prime-age adults aged 18 to 64 substantially increased in 2020 and onward, even with COVID-19 deaths excluded, according to a Dec. 15, 2022, paper that attempted to account for COVID-19 deaths misclassified on death certificates.

Read more here...

Tyler Durden Tue, 01/31/2023 - 18:20

Read More

Continue Reading